Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pembrolizumab monotherapy in patients with primary refractory classical hodgkin lymphoma who relapsed after salvage autologous stem cell transplantation and/or brentuximab vedotin therapy: KEYNOTE-087 subgroup analysis.
Zinzani PL, Chen R, Armand P, Johnson NA, Brice P, Radford J, Ribrag V, Molin D, Vassilakopoulos TP, Tomita A, von Tresckow B, Shipp MA, Lin J, Nahar A, Balakumaran A, Moskowitz CH. Zinzani PL, et al. Among authors: balakumaran a. Leuk Lymphoma. 2020 Apr;61(4):950-954. doi: 10.1080/10428194.2019.1702178. Epub 2020 Jan 6. Leuk Lymphoma. 2020. PMID: 31905294 Free PMC article. No abstract available.
Patient-reported outcomes in KEYNOTE-087, a phase 2 study of pembrolizumab in patients with classical Hodgkin lymphoma.
von Tresckow B, Fanale M, Ardeshna KM, Chen R, Meissner J, Morschhauser F, Moskowitz C, Zinzani PL, Giezek H, Balakumaran A, Vo TT, Raut M, Brice P. von Tresckow B, et al. Among authors: balakumaran a. Leuk Lymphoma. 2019 Nov;60(11):2705-2711. doi: 10.1080/10428194.2019.1602262. Epub 2019 Apr 23. Leuk Lymphoma. 2019. PMID: 31012356 Clinical Trial.
Evaluating results from the multiple myeloma patient subset treated with denosumab or zoledronic acid in a randomized phase 3 trial.
Raje N, Vadhan-Raj S, Willenbacher W, Terpos E, Hungria V, Spencer A, Alexeeva Y, Facon T, Stewart AK, Feng A, Braun A, Balakumaran A, Roodman GD. Raje N, et al. Among authors: balakumaran a. Blood Cancer J. 2016 Jan 8;6(1):e378. doi: 10.1038/bcj.2015.96. Blood Cancer J. 2016. PMID: 26745852 Free PMC article. Clinical Trial.
Global transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency.
Ren J, Jin P, Sabatino M, Balakumaran A, Feng J, Kuznetsov SA, Klein HG, Robey PG, Stroncek DF. Ren J, et al. Among authors: balakumaran a. Cytotherapy. 2011 Jul;13(6):661-74. doi: 10.3109/14653249.2010.548379. Epub 2011 Jan 20. Cytotherapy. 2011. PMID: 21250865 Free PMC article.
The establishment of a bank of stored clinical bone marrow stromal cell products.
Sabatino M, Ren J, David-Ocampo V, England L, McGann M, Tran M, Kuznetsov SA, Khuu H, Balakumaran A, Klein HG, Robey PG, Stroncek DF. Sabatino M, et al. Among authors: balakumaran a. J Transl Med. 2012 Feb 6;10:23. doi: 10.1186/1479-5876-10-23. J Transl Med. 2012. PMID: 22309358 Free PMC article.
47 results